US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sandridge Energy Inc.

9.40

+0.29003.18%

Volume:54.25K

Turnover:505.34K

Market Cap:348.67M

PE:5.56

High:9.42

Open:9.17

Low:9.11

Close:9.11

Loading ...

Overview Company News Filings

Verizon Communications (NYSE:VZ) Launches FedRAMP High Ready SD WAN For Federal Agencies

Simply Wall St.

EnerCom Opens Registration for the 30th Annual EnerCom Denver - The Energy Investment Conference

GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting

BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma

ACCESS Newswire

With 71% ownership, SandRidge Energy, Inc. (NYSE:SD) boasts of strong institutional backing

Simply Wall St.

Fortinet (NasdaqGS:FTNT) Powers Bell's SD-WAN-as-a-Service With Enhanced Security

Simply Wall St.

SD Guthrie's Industrial Park Deal Likely to Unlock Land Value -- Market Talk

Dispute Arises as Free Meal's Kitchen Partner Claims Nearly Rp 1 Billion Unpaid

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

People's School to Implement Prabowo Govt's Free Meal Program, Minister Says

Create SD Holdings Sees FY Net Y14.40B

Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose

SandRidge Energy Down Over 7%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk

UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

ASUS Republic of Gamers Announces ROG Strix SCAR, Strix G18, and Zephyrus, Are Now Available and Shipping

Press Release: Harbour BioMed Reports Full Year 2024 Financial Results

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

BioInvent’s anti-TNFR2 antibody BI-1808 showcased at the 16th Annual T-Cell Lymphoma Forum

ACCESS Newswire

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SD\",,,,,undefined,":{"symbol":"SD","market":"US","secType":"STK","nameCN":"Sandridge Energy Inc.","latestPrice":9.4,"timestamp":1746111241741,"preClose":9.11,"halted":0,"volume":54254,"delay":0,"floatShares":36549742,"shares":37092231,"eps":1.69,"marketStatus":"Trading","change":0.29,"latestTime":"05-01 10:54:10 EDT","open":9.165,"high":9.42,"low":9.11,"amount":505340.419376,"amplitude":0.034029,"askPrice":9.41,"askSize":59,"bidPrice":9.38,"bidSize":52,"shortable":3,"etf":0,"ttmEps":1.69,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1475553600000,"exchange":"NYSE","adjPreClose":9.11,"dividendRate":0.046809,"preHourTrading":{"tag":"盘前","latestPrice":9,"preClose":9.11,"latestTime":"08:00 EDT","volume":91,"amount":824.1227085,"timestamp":1746100800281},"postHourTrading":{"tag":"盘后","latestPrice":9.2893,"preClose":9.11,"latestTime":"17:51 EDT","volume":7155,"amount":65199.98,"timestamp":1746049912319},"volumeRatio":0.998157,"impliedVol":0.6425,"impliedVolPercentile":0.896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SD\",,,,,undefined,":{"symbol":"SD","floatShares":36549742,"roa":"3.65%","roe":"13.57%","lyrEps":1.697461,"volumeRatio":0.998157,"shares":37092231,"dividePrice":0.44,"high":9.42,"amplitude":0.034029,"preClose":9.11,"low":9.11,"week52Low":8.81,"pbRate":"0.76","psRate":"2.78","week52High":14.24,"institutionHeld":0,"latestPrice":9.4,"committee":-0.063063,"eps":1.69,"divideRate":0.046809,"volume":54254,"delay":0,"ttmEps":1.69,"open":9.165,"prevYearClose":11.71,"prevWeekClose":9.52,"prevMonthClose":9.11,"prevQuarterClose":11.42,"fiveDayClose":9.36,"twentyDayClose":11.38,"sixtyDayClose":12.14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532206482","title":"Verizon Communications (NYSE:VZ) Launches FedRAMP High Ready SD WAN For Federal Agencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2532206482","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532206482?lang=en_us&edition=fundamental","pubTime":"2025-05-01 01:52","pubTimestamp":1746035528,"startTime":"0","endTime":"0","summary":"Verizon Communications recently launched its first Government Cloud-Managed SD WAN product, specifically designed for U.S. federal agencies, marking a significant step in enhancing security and scalability for government clients. Over the past quarter, Verizon's share price rose 7%, closely aligned with the broader market's 5% gain. The company's robust earnings report, alongside strategic initiatives like the SD WAN product and expanded partnerships in IoT services, likely added weight to its stock performance, particularly amidst a contracting economy and sliding economic indicators, which saw declines in other tech giants like Meta and Amazon.Be aware that Verizon Communications is showing 2 risks in our investment analysis.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verizon-communications-nyse-vz-launches-175208479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1699723380.USD","LU0098860793.USD","US2Y.BOND","LU0985481810.HKD","LU0306806265.USD","US12M.BOND","LU1585245621.USD","LU1621767810.EUR","LU0321505439.SGD","LU0320765646.SGD","LU1914381329.SGD","IE00BSNM7G36.USD","LU1066051498.USD","LU0225284248.USD","LU0321505868.SGD","SD","BK4115","LU1066051225.USD","LU1066053197.SGD","US10Y.BOND","BK4213","BK4581","LU1162221912.USD","BK4550","LU1621768115.EUR","BK4534","LU0868494617.USD","LU1571399168.USD","US3Y.BOND","BK4533","NYSE","VZ","LU0942090050.USD","US30Y.BOND","BK4585","LU1430594728.SGD","US6M.BOND","US7Y.BOND","LU0306807586.USD","LU1366192091.USD","LU1621767737.EUR","LU0868494708.USD","BK4515","LU0225771236.USD","LU2384288077.EUR","BK4588","LU1059921491.USD","US5Y.BOND","LU1621768206.USD","BK4559"],"gpt_icon":0},{"id":"2531216761","title":"EnerCom Opens Registration for the 30th Annual EnerCom Denver - The Energy Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216761","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531216761?lang=en_us&edition=fundamental","pubTime":"2025-04-30 01:17","pubTimestamp":1745947020,"startTime":"0","endTime":"0","summary":"Join us as we celebrate three decades of bringing together the energy industry's companies, investors, analysts, and industryleaders!DENVER, April 29, 2025 /PRNewswire/ -- EnerCom, Inc. today opened registration for its 30th annual EnerCom Denver – The Energy Investment Conference to be held August 17-20, 2025, at the Westin Denver Downtown. Come celebrate as EnerCom once again hosts the broader energy sector, including public and private companies, investors, analysts, and industry leaders. Institutional investors, family offices, portfolio managers, financial analysts, CIOs, and other investment community and industry professionals are encouraged to register.The conference allows investors unparalleled networking opportunities, including one-on-one meetings with company management teams. Meetings are limited to buy-side principals, portfolio managers, CIOs, and securities analysts. Qualified investment professionals and oil and gas company executives may register for the conference a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/enercom-opens-registration-30th-annual-171700698.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enercom-opens-registration-30th-annual-171700698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GTE","LU0300736492.USD","LU0788109394.HKD","MNR","NCSM","LU0787776722.HKD","BTE","AMPY","USAW.SI","USJW.SI","SD","EOG","BK4585","TSYW.SI","OKLO","BKV","IE0031619046.USD","BK4171",".IXIC","ZPHRF","E","LU2237438978.USD","SQQQ","QID","BK4606","QLD","VTS","FTK","LU0130517989.USD","REI","LU0980610538.SGD","NEHCW","DEC","OILSF","NEHC","WTTR","LBRT","BRY","LU0320765489.SGD","PSQ","LU0300736062.USD","BK4213","MNQmain","DTI","LU0053666078.USD","SM","TQQQ","NVIW.SI","IE00B2Q91V27.USD","NQmain","BK4563","DNOW"],"gpt_icon":1},{"id":"2531765670","title":"GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531765670","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531765670?lang=en_us&edition=fundamental","pubTime":"2025-04-30 00:00","pubTimestamp":1745942400,"startTime":"0","endTime":"0","summary":"Advancing Gene-Directed Prodrug Therapy: Data Presented at AACR Supports Gedeptin's Potential in Solid Tumors. ATLANTA, GA - April 29, 2025  - GeoVax Labs, Inc. , a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the presentation of new clinical data on its gene-directed enzyme prodrug therapy, Gedeptin, at the American Association for Cancer Research  Annual Meeting 2025, being held April 2530 in Chicago, IL.The presentation, titled \"Viral-Vectored, Gene-Directed Prodrug Therapy  in Needle-Accessible Solid Tumors,\" was delivered by J. Marc Pipas, M.D., Executive Medical Director, Oncology at GeoVax, during the Phase II Clinical Trials 1 Poster Session on April 29, 2025. The session drew significant interest from researchers and clinicians, underscoring the growing recognition of Gedeptin's therapeutic potential. The corresponding abstract was published in the AACR journal Cancer Research.\"These clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geovax-presents-gedeptin-r-clinical-160000847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2362541513.USD","BK4117","BK4134","IT","BK4583","LU2517655374.HKD","LU2362540622.SGD","AFG","R","OS","GOVX","BK4211","GOVXW","BK4139","SD","BK4232","PFS","LU2517655028.SGD","LU2517655291.USD","LU0154245673.USD","BK4022","BK4195","BK4107","BK4585","LU0107464264.USD","LU0154245756.USD","LU2362541273.HKD","BK4097","BK4588","BK4213","LU1814569148.SGD"],"gpt_icon":0},{"id":"2531557200","title":"BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2531557200","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531557200?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:15","pubTimestamp":1745921700,"startTime":"0","endTime":"0","summary":"LUND, SE / ACCESS Newswire / April 29, 2025 / BioInvent International AB  , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announces that the U.S. Food and Drug Administration  has granted Fast Track Designation to BI-1808, a first-in-class anti-TNFR2 antibody, for the treatment of adults with relapsed or refractory mycosis fungoides and Sézary syndrome, subtypes of cutaneous T-cell lymphoma . Fast Track Designation  is intended to facilitate the development and review of drugs that treat serious conditions.About Phase 1/2a studyDuring the first part of the Phase 1/2a study  the safety, tolerability, and potential signs of efficacy of BI-1808 as a single agent  and in combination with the anti-PD-1 therapy pembrolizumab  are evaluated in patients with advanced solid tumors and T-cell lymphoma. The efficacy of BI-1808 as single agent is currently explored in the Phase 2a part of the tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioinvent-receives-fda-fast-track-101500462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CR","BK4213","PR","FAST","SD","BOVNF","BK4161","BK4139"],"gpt_icon":0},{"id":"2530129234","title":"With 71% ownership, SandRidge Energy, Inc. (NYSE:SD) boasts of strong institutional backing","url":"https://stock-news.laohu8.com/highlight/detail?id=2530129234","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530129234?lang=en_us&edition=fundamental","pubTime":"2025-04-26 20:46","pubTimestamp":1745671595,"startTime":"0","endTime":"0","summary":"Institutions' substantial holdings in SandRidge Energy implies that they have significant influence over the company's share price. 50% of the business is held by the top 13 shareholders. Ownership research, combined with  past performance data  can help provide a good understanding of opportunities in a stock. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.A look at the shareholders of SandRidge Energy, Inc.  can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 71% ownership. In other words, the group stands to gain the most  from their investment into the company.Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of inst","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/71-ownership-sandridge-energy-inc-124635780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SD","NYSE","BK4213"],"gpt_icon":0},{"id":"2530169339","title":"Fortinet (NasdaqGS:FTNT) Powers Bell's SD-WAN-as-a-Service With Enhanced Security","url":"https://stock-news.laohu8.com/highlight/detail?id=2530169339","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530169339?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:44","pubTimestamp":1745603074,"startTime":"0","endTime":"0","summary":"The recent collaboration announced on April 24, 2025, between Bell and Fortinet, where the latter's Secure SD-WAN technology will enhance Bell's managed SD-WAN-as-a-Service, could have added weight to Fortinet's recent share price movement, which rose by approximately 5% over the last week. This positive development comes amid mixed market sentiment, as broader tech stocks saw varying results influenced by earnings reports and uncertainties around tariffs. While the tech-heavy Nasdaq gained marginally, Fortinet's gains suggest that the partnership announcement and the potential for enhanced service offerings provided support within this broader market context.View our complete analysis and fair value estimate and you decide.NasdaqGS:FTNT Earnings Per Share Growth as at Apr 2025. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fortinet-nasdaqgs-ftnt-powers-bells-174434641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1974910355.USD","LU2023250504.SGD","BK4585","SD","FTNT","IE0008368304.USD","LU2286300806.USD","BK4560","BK4213","BK4588","LU2106854487.HKD","BK4532","LU0348723411.USD","LU2023250843.SGD","LU0079474960.USD","BK4097","LU1917777945.USD"],"gpt_icon":0},{"id":"2529881464","title":"SD Guthrie's Industrial Park Deal Likely to Unlock Land Value -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2529881464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529881464?lang=en_us&edition=fundamental","pubTime":"2025-04-21 10:26","pubTimestamp":1745202360,"startTime":"0","endTime":"0","summary":"0226 GMT - SD Guthrie's recent deal to co-develop a MYR2.95 billion industrial park in Negeri Sembilan, Malaysia, appears to be a positive move, says Hong Leong IB analyst Chye Wen Fei. The deal reaffirms the palm oil producer's effort to monetize its strategically located landbank while leveraging its partners' expertise, the analyst says in a note. SD Guthrie will hold a 30% stake in the 1,195-acre project with Eco World Development and NS Corp. Hong Leong raises SD Guthrie's rating to buy from hold as its valuation turns attractive following the recent sell-down, while maintaining a target price of MYR5.09. Shares are 0.7% higher at MYR4.63. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SD"],"gpt_icon":0},{"id":"2527404158","title":"Dispute Arises as Free Meal's Kitchen Partner Claims Nearly Rp 1 Billion Unpaid","url":"https://stock-news.laohu8.com/highlight/detail?id=2527404158","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527404158?lang=en_us&edition=fundamental","pubTime":"2025-04-16 08:33","pubTimestamp":1744763599,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - The kitchen partner of Prabowo's Free Meal program  at the Nutrition Fulfillment Service Unit  in Kalibata, South Jakarta, plans to pursue legal action after incurring a loss of nearly Rp1 billion, precisely Rp975,375,000. Danna Harly Putra, the legal representative, explained that the loss was suffered because his client, Ira Mesra, as a partner, has not received a single penny in payment since the kitchen began operating in February 2025.Harly stated that the legal action will be in the form of a civil lawsuit and reporting to the police. \"Therefore, against the foundation's action of not paying a single penny of our client's rights in the implementation of the Free Nutritious Meal, we will take legal action,\" said Harly at a press conference in Kalibata on Tuesday, April 15, 2025.","market":"nz","thumbnail":"https://statik.tempo.co/data/2025/04/15/id_1391901/1391901_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/04/15/id_1391901/1391901_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1997256/dispute-arises-as-free-meals-kitchen-partner-claims-nearly-rp-1-billion-unpaid","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["SD","BK4213","MBG"],"gpt_icon":0},{"id":"2527814287","title":"Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527814287","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527814287?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:15","pubTimestamp":1744661700,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., April 14, 2025----Bristol Myers Squibb  today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos  for the treatment of adult patients with symptomatic New York Heart Association  class II-III non-obstructive hypertrophic cardiomyopathy  did not meet its dual primary endpoints of changes from baseline to Week 48 compared to placebo in the Kansas City Cardiomyopathy Questionnaire – Clinical Summary Score  and peak oxygen consumption . No new safety signals were observed.\"While these results are disappointing, the ODYSSEY-HCM trial meaningfully contributes to the understanding of non-obstructive HCM, a disease where there remains a significant need for new treatment options,\" said Roland Chen, MD, senior vice president, drug development, Immunology and Cardiovascular Medicines, Bristol Myers Squibb. \"These findings represent the first Phase 3 clinical trial data for a cardiac myosin inhibitor in non-obstructive HCM. Importantly, these results do not change the fav","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-provides-phase-201500074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU1032466523.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","MYE","BK4585","LU2360032135.SGD","LU2242646821.SGD","IE0009355771.USD","LU1868836591.USD","LU1093756168.USD","LU1989771016.USD","LU0882574055.USD","BK4126","LU1670710661.SGD","HCM","BK4531","LU1323610961.USD","LU0456855351.SGD","LU1670710588.SGD","BK4213","BK4559","LU1868837136.USD","LU0306806265.USD","LU1868837300.USD","BK4532","LU1291159041.SGD","IE00B2B36J28.USD","LU1571399168.USD","BK4534","SD","LU2242652126.USD","LU1585245621.USD","LU0225771236.USD","LU1868836757.USD","LU1261432733.SGD","BMY","LU2125154935.USD","BK4581","LU1670711123.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU0321505868.SGD","BK4007","LU0868494617.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2133065610.SGD","LU0061475181.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2526158318","title":"People's School to Implement Prabowo Govt's Free Meal Program, Minister Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2526158318","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526158318?lang=en_us&edition=fundamental","pubTime":"2025-04-09 23:37","pubTimestamp":1744213025,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - The Indonesian government will start operating the free schools, or People’s School , in July this year. The initial stage will be limited to high schools, managed by the Ministry of Social Affairs, but President Prabowo intends to expand the school operation to junior high  and primary school .Led by Mohammad Nuh, the People’s School formation team will begin recruiting students and teachers this month. Social Affairs Minister Saifullah Yusuf said the school will require over 1,000 teachers across 53 locations.People’s School Ready to Synergize with MBG Program","market":"fut","thumbnail":"https://statik.tempo.co/data/2025/03/08/id_1383038/1383038_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/03/08/id_1383038/1383038_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1995090/peoples-school-to-implement-prabowo-govts-free-meal-program-minister-says","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4124","BK7033","BK4213","BK7500","SD","SMP","SMP.AU","BK7158"],"gpt_icon":0},{"id":"2525066980","title":"Create SD Holdings Sees FY Net Y14.40B","url":"https://stock-news.laohu8.com/highlight/detail?id=2525066980","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525066980?lang=en_us&edition=fundamental","pubTime":"2025-04-07 14:30","pubTimestamp":1744007400,"startTime":"0","endTime":"0","summary":"Create SD Holdings Co. Ltd. also released the following forecasts: GROUPYear Ending May 2025 RevenueY457.60 bln Operating ProfitY22.00 bln Pretax ProfitY22.40 bln Net ProfitY14.40 bln Per share EarningsY222.90 Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SD","BK4213"],"gpt_icon":0},{"id":"2524017002","title":"Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2524017002","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524017002?lang=en_us&edition=fundamental","pubTime":"2025-04-04 21:00","pubTimestamp":1743771600,"startTime":"0","endTime":"0","summary":"Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq) The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg in combination w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/04/3055960/0/en/Sonnet-s-SON-1010-Demonstrates-a-Strong-Safety-Profile-in-Combination-with-Atezolizumab-for-Treatment-of-Platinum-Resistant-Ovarian-Cancer-Including-a-Partial-Response-at-the-Highe.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TME","BK4565","BK4213","SON","LU0359201612.USD","LU2413666699.HKD","BK4080","SG9999011746.SGD","BK4139","SD","BK4552","SONN","BK4136","BK4231","BK4563","SRC","LU1023057109.AUD","LU1093756325.SGD","PROC","PD","BK4548","LU2039709279.SGD","LU0359202008.SGD","LU1093756168.USD","BK4585","BK4181","BK4509","LU1169590202.USD","PR","BK4571","LU1169589451.USD","BK4531","IE00B12V2V27.USD","BK4023","MTD","LU1721428933.USD","BK4218","BK4567","BK4588","IE00BYQQ9H92.USD","BK4533","01698","PK","BK4007","IE00BFXG0V08.USD","BK4108","BK4526","IE00BYTNYN87.SGD","BK4121","BK4535"],"gpt_icon":0},{"id":"2524267437","title":"SandRidge Energy Down Over 7%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2524267437","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524267437?lang=en_us&edition=fundamental","pubTime":"2025-04-03 23:30","pubTimestamp":1743694200,"startTime":"0","endTime":"0","summary":"SandRidge Energy, Inc.  is currently at $10.54, down $0.84 or 7.38%. --Would be lowest close since Dec. 23, 2024, when it closed at $10.50. --On pace for largest percent decrease since Feb. 2, 2024, when it fell 18.58%. --Currently down two consecutive days; down 7.95% over this period. --Down 62.83% from its all-time closing high of $28.36 on June 7, 2022. --Down 29.73% from 52 weeks ago , when it closed at $15.00. --Down 30.11% from its 52-week closing high of $15.08 on April 5, 2024. --Up 0.38% from its 52-week closing low of $10.50 on Dec. 23, 2024. --Traded as low as $10.42; lowest intraday level since Dec. 24, 2024, when it hit $10.42. --Down 8.44% at today's intraday low; largest intraday percent decrease since June 3, 2024, when it fell as much as 10.94%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SD","BK4213"],"gpt_icon":0},{"id":"2524303052","title":"UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524303052","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524303052?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:00","pubTimestamp":1743678000,"startTime":"0","endTime":"0","summary":"24 scientific abstracts reflect UCB's ongoing commitment to improving outcomes for people living with neurological conditions, including rare epilepsies Dravet syndrome and Lennox-Gastaut syndrome, as well as generalized myasthenia gravis and thymidine kinase 2 deficiency.Research includes disease course data of untreated patients with thymidine kinase 2 deficiency from largest international dataset.Also features new data on generalized myasthenia gravis treatments RYSTIGGO1  and ZILBRYSQ2  including an open-label extension study investigating rozanolixizumab self-administration and a phase 3 study on the effect of zilucoplan on specific outcome scores.\"We at UCB are deeply committed to driving innovation to improve the treatment and care of people living with severe neurological and neuromuscular conditions such as epilepsy, gMG, and TK2d. The data presented at AAN is a testament to our dedication to exploring new frontiers of science and improving care in areas of high unmet need. It","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ucb-presents-latest-research-across-110000212.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ucb-presents-latest-research-across-110000212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SD","FFA","IE00BD6J9T35.USD","BK4135","BK4178","BK4168","BK4588","BK4211","BK4585","UCBJY","CNS","MP","AFG","UCB","BK4107","BK4213","UCBJF","BK4117","BK4007","AAN"],"gpt_icon":0},{"id":"2524194196","title":"Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2524194196","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524194196?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one complete response, compared to 5.3% ORR for paclitaxel alone,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053162/0/en/Tovecimig-CTX-009-Meets-Primary-Endpoint-in-the-Ongoing-Randomized-Phase-2-3-Study-in-Patients-with-Biliary-Tract-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","BK4195","BK4161","BTC","PD","IE00B19Z3B42.SGD","BK4213","LU1169590202.USD","IE00B19Z3581.USD","ORR","BK4139","PFS","OS","BK4023","CR","BK4211","LU1169589451.USD","BK4097","IE00B7SZLL34.SGD","PR","SD","CMPX","NE","BK4092"],"gpt_icon":0},{"id":"2523182940","title":"ASUS Republic of Gamers Announces ROG Strix SCAR, Strix G18, and Zephyrus, Are Now Available and Shipping","url":"https://stock-news.laohu8.com/highlight/detail?id=2523182940","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523182940?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:39","pubTimestamp":1743428340,"startTime":"0","endTime":"0","summary":"ROG begins shipping the next generation RTX 50 Series of Laptop GPU equipped devices. FREMONT, Calif., March 31, 2025 /PRNewswire/ --ASUS Republic of Gamers  today announced that it has begun shipping their much-anticipated NVIDIA GeForce RTX Series equipped line-up of laptops after initial unveil at CES 2025 subsequent pre-order on February 25, 2025. ASUS ROG's line up of GeForce RTX Series Laptop GPUs include: ROG Strix SCAR 16 and SCAR 18; ROG Strix G18; and ROG Zephyrus G14 and G16. Featuring the latest cutting-edge silicon from Intel and NVIDIA, our portable line up is designed to deliver the power and performance that gamers can expect without compromise.Both models are equipped with dual PCIe Gen 4.0 SSD slots and designed for tool-less access, with Intel models supporting PCIe Gen 5 on both slots this allows for seamless storage upgrades.With customizable hotkey","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/asus-republic-gamers-announces-rog-133900300.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asus-republic-gamers-announces-rog-133900300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVDX","LU1043141123.HKD","LU1564329032.USD","NVDS","LU0149725797.USD","LU2237443549.SGD","LU2275660780.HKD","USAW.SI","ASUUY","ACR","GEN","LU2506952170.USD","NVDY","LU1670627923.USD","NVD","NVD3.UK","HK0000306685.HKD","SNVD.UK","NVDD","SD","LU0130102774.USD","LU1951198990.SGD","LU2404859667.USD","NVDU","LU2265009873.SGD","2NVD.UK","GB00BDT5M118.USD","RTX","3NVD.UK","BK4548","LU1935042488.USD","SDR","NVIW.SI","NVDS.UK","LU2125154935.USD","LU1670628061.USD","NVD2.UK","ROG","LU1852331112.SGD","LU1934455277.USD","USB","LU2237443382.USD","LU0308772762.SGD","LU2720916845.USD","LU2092937221.SGD"],"gpt_icon":1},{"id":"2523191987","title":"Press Release: Harbour BioMed Reports Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523191987","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523191987?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:13","pubTimestamp":1743415980,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025. CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed , a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its financial results for the year ended December 31, 2024.Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed,  commented: \"The year 2024 was a pivotal period for Harbour BioMed, marked by significant progress in research and development, strategic business expansion, and operational excellence. Despite a challenging macroeconomic environment, the Company demonstrated remarkable resilience, navigating inflationary pressures, global supply chain disruptions, and geopolitical uncertainties while remaining focused on its long-term growth objectives.Compared to 2023, the company's revenue sustainability has continued to improve. Annual recurring revenue in","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4099","R","BK4022","BK1574","TSLP","BK4604","BK1161","BK1583","BK4555","SD","02142","TM","03160","BK4213","BK4232","BK4588"],"gpt_icon":0},{"id":"2522558078","title":"Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522558078","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522558078?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"– Initial clinical activity in a PD-1 resistant population, with an ORR almost three times higher than historical PD-1 rechallenge response rates, with data still maturing –。– One durable complete response in a Merkel Cell Carcinoma  patient and two partial responses , including one in a second MCC patient and one in a microsatellite instability-high  Colorectal Cancer  patient, all of whom were previously treated with and progressed on immunotherapy –。– All PD-1 resistant “hot” tumor patients with tumor shrinkage remain on study, suggesting potential for deepening responses over time –。The Phase 1 dose expansion trial is a multi-center, open-label, dose expansion study evaluating solnerstotug as monotherapy and in combination withLibtayo , Regeneron’s PD-1 inhibitor, in both a basket of “hot” tumorsthat typically respond to immunotherapy but have progressed on prior PD-1 therapy and a single “cold” tumor histology  that is typically unresponsive to immunotherapy.At the time of this da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sensei-biotherapeutics-reports-favorable-preliminary-200500147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4006","MSS","BK4023","LU1169589451.USD","PR","SD","BK4585","LU0053666078.USD","IE00B19Z4B17.USD","BK4080","SITC","CRS","BK4213","PD","BK4161","LU1169590202.USD","LU2065731478.USD","IE00B66KJ199.SGD","CR","BK4113","IE0031619046.USD","SNSE","RCC","LU0456854461.SGD","BK4139","LU0266512127.USD","IE00B7SZL793.SGD","CRC","BK4231","BK4588","L","BK4107"],"gpt_icon":0},{"id":"2522027846","title":"Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2522027846","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522027846?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:05","pubTimestamp":1742904300,"startTime":"0","endTime":"0","summary":"Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer’s diseaseSimufilam continued to dem","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/25/3048697/8339/en/Cassava-Sciences-Reports-Topline-Phase-3-REFOCUS-ALZ-Data.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SD","SAVA","BK4547","BK4588","BK4213","BK4007"],"gpt_icon":0},{"id":"2521200024","title":"BioInvent’s anti-TNFR2 antibody BI-1808 showcased at the 16th Annual T-Cell Lymphoma Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2521200024","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521200024?lang=en_us&edition=fundamental","pubTime":"2025-03-21 15:20","pubTimestamp":1742541600,"startTime":"0","endTime":"0","summary":"BioInvent International AB  , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced that one of the company's lead program; BI-1808 as monotherapy in Cutaneous T Cell Lymphoma  will be presented at the 16th Annual T-Cell Lymphoma Forum held March 20-22, 2025 in La Jolla, California.The data, previously disclosed in a press release in September 2024, will be featured in a poster presentation highlighting the early efficacy of BI-1808 monotherapy in the ongoing Phase 2a dose expansion study in CTCL. So far three partial responses  and one stable disease  out of four evaluable patients have been reported. The Company anticipates reporting additional data from the study in mid-2025.BI-1808, a first-in-class anti-TNFR2 antibody, was recently granted Orphan Drug Designation by the U.S. Food and Drug Administration  for the treatment of TCL.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioinvent-anti-tnfr2-antibody-bi-072000423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","SD","BOVNF","FET","BK4213","BK4139","PR","BK4179","CR"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":94,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SD\",params:#limit:5,,,undefined,":[{"date":"2025-03-20","symbol":"SD","amount":0.11,"announcedDate":"2025-03-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-20","defaultRemindTime":1742477400000,"name":"SandRidge Energy","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-20","currency":"USD","dateTimestamp":1742443200000,"payDate":"2025-03-31"},{"market":"US","date":"2025-03-10","symbol":"SD","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"pre","actualEps":0.34},{"date":"2024-11-15","symbol":"SD","amount":0.11,"announcedDate":"2024-11-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-15","defaultRemindTime":1731681000000,"name":"SandRidge Energy","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-29","payableDate":"2024-11-15","currency":"USD","dateTimestamp":1731646800000,"payDate":"2024-11-29"},{"market":"US","date":"2024-11-06","symbol":"SD","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":0.19},{"date":"2024-08-16","symbol":"SD","amount":0.11,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-16","defaultRemindTime":1723815000000,"name":"SandRidge Energy","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-30","payableDate":"2024-08-16","currency":"USD","dateTimestamp":1723780800000,"payDate":"2024-08-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SD\",market:\"US\",,,undefined,":[{"executeDate":"2023-05-23","recordDate":"2023-05-24","paymentDate":"2023-06-07","value":2,"currency":"USD"},{"executeDate":"2023-08-11","recordDate":"2023-08-14","paymentDate":"2023-08-28","value":0.1,"currency":"USD"},{"executeDate":"2023-11-10","recordDate":"2023-11-13","paymentDate":"2023-11-27","value":0.1,"currency":"USD"},{"executeDate":"2024-02-02","recordDate":"2024-02-05","paymentDate":"2024-02-20","value":1.5,"currency":"USD"},{"executeDate":"2024-03-14","recordDate":"2024-03-15","paymentDate":"2024-03-29","value":0.11,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1722657600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SD","date":"2025-04-30","current":5.435514,"percent":0.655004,"low":-1.152579,"twenty":-0.101576,"median":3.654931,"eighty":8.933445,"high":209.684554,"avg":12.685685,"sd":37.645064,"marketCap":342361292},"quantilePoints":[{"date":"2020-05-01","current":-0.156647,"twenty":-3.133467,"median":-0.222111,"eighty":1.575586,"marketCap":70382058},{"date":"2020-05-08","current":-0.148735,"twenty":-3.117561,"median":-0.220786,"eighty":1.575586,"marketCap":66827408},{"date":"2020-05-15","current":-0.11788,"twenty":-3.04097,"median":-0.220027,"eighty":1.575586,"marketCap":52964276},{"date":"2020-05-22","current":-0.114416,"twenty":-3.04097,"median":-0.21928,"eighty":1.575586,"marketCap":52253346},{"date":"2020-05-29","current":-0.122977,"twenty":-3.04097,"median":-0.217481,"eighty":1.575586,"marketCap":56163460},{"date":"2020-06-05","current":-0.140101,"twenty":-2.99804,"median":-0.21582,"eighty":1.575586,"marketCap":63983689},{"date":"2020-06-12","current":-0.129204,"twenty":-2.97896,"median":-0.213947,"eighty":1.575586,"marketCap":59007180},{"date":"2020-06-19","current":-0.105075,"twenty":-2.950339,"median":-0.211094,"eighty":1.575586,"marketCap":47987766},{"date":"2020-06-26","current":-0.101962,"twenty":-2.890333,"median":-0.207997,"eighty":1.575586,"marketCap":46565907},{"date":"2020-07-02","current":-0.101184,"twenty":-2.816779,"median":-0.205444,"eighty":1.575586,"marketCap":46210442},{"date":"2020-07-10","current":-0.101962,"twenty":-2.816779,"median":-0.199194,"eighty":1.575586,"marketCap":46565907},{"date":"2020-07-17","current":-0.100405,"twenty":-2.735737,"median":-0.190689,"eighty":1.575586,"marketCap":45854977},{"date":"2020-07-24","current":-0.105854,"twenty":-2.735737,"median":-0.182973,"eighty":1.575586,"marketCap":48343231},{"date":"2020-07-31","current":-0.101184,"twenty":-2.734988,"median":-0.181048,"eighty":1.575586,"marketCap":46210442},{"date":"2020-08-07","current":-0.091762,"twenty":-2.734988,"median":-0.178762,"eighty":1.575586,"marketCap":60489194},{"date":"2020-08-14","current":-0.100399,"twenty":-2.701686,"median":-0.177271,"eighty":1.575586,"marketCap":66182294},{"date":"2020-08-21","current":-0.085285,"twenty":-2.701686,"median":-0.176827,"eighty":1.575586,"marketCap":56219368},{"date":"2020-08-28","current":-0.086365,"twenty":-2.701686,"median":-0.17579,"eighty":1.575586,"marketCap":56931006},{"date":"2020-09-04","current":-0.09716,"twenty":-2.699251,"median":-0.173865,"eighty":1.575586,"marketCap":64047382},{"date":"2020-09-11","current":-0.087984,"twenty":-2.699251,"median":-0.172434,"eighty":1.575586,"marketCap":57998462},{"date":"2020-09-18","current":-0.101479,"twenty":-2.699251,"median":-0.171273,"eighty":1.575586,"marketCap":66893932},{"date":"2020-09-25","current":-0.089603,"twenty":-2.699251,"median":-0.169269,"eighty":1.575586,"marketCap":59065919},{"date":"2020-10-02","current":-0.086904,"twenty":-2.699251,"median":-0.166757,"eighty":1.575586,"marketCap":57286825},{"date":"2020-10-09","current":-0.102558,"twenty":-2.680658,"median":-0.163869,"eighty":1.575586,"marketCap":67605570},{"date":"2020-10-16","current":-0.089064,"twenty":-2.66132,"median":-0.161869,"eighty":1.575586,"marketCap":58710100},{"date":"2020-10-23","current":-0.103638,"twenty":-2.66132,"median":-0.160018,"eighty":1.575586,"marketCap":68317207},{"date":"2020-10-30","current":-0.092842,"twenty":-2.66132,"median":-0.157438,"eighty":1.575586,"marketCap":61200831},{"date":"2020-11-06","current":-0.143096,"twenty":-2.66132,"median":-0.155575,"eighty":1.55101,"marketCap":75317355},{"date":"2020-11-13","current":-0.179718,"twenty":-2.66132,"median":-0.157575,"eighty":1.488204,"marketCap":94592886},{"date":"2020-11-20","current":-0.181753,"twenty":-2.66132,"median":-0.160907,"eighty":1.442693,"marketCap":95663749},{"date":"2020-11-27","current":-0.195316,"twenty":-2.66132,"median":-0.161869,"eighty":1.390651,"marketCap":102802835},{"date":"2020-12-04","current":-0.199385,"twenty":-2.66132,"median":-0.163276,"eighty":1.276397,"marketCap":104944561},{"date":"2020-12-11","current":-0.210915,"twenty":-2.66132,"median":-0.166106,"eighty":1.218547,"marketCap":111012784},{"date":"2020-12-18","current":-0.213627,"twenty":-2.66132,"median":-0.167688,"eighty":1.104442,"marketCap":112440601},{"date":"2020-12-24","current":-0.214305,"twenty":-2.66132,"median":-0.170015,"eighty":0.955137,"marketCap":112797555},{"date":"2020-12-31","current":-0.210236,"twenty":-2.66132,"median":-0.171422,"eighty":0.844957,"marketCap":110655829},{"date":"2021-01-08","current":-0.238042,"twenty":-2.66132,"median":-0.172458,"eighty":0.774908,"marketCap":125290955},{"date":"2021-01-15","current":-0.339769,"twenty":-2.66132,"median":-0.174458,"eighty":0.729304,"marketCap":178834099},{"date":"2021-01-22","current":-0.318746,"twenty":-2.66132,"median":-0.175864,"eighty":0.623137,"marketCap":167768516},{"date":"2021-01-29","current":-0.286193,"twenty":-2.66132,"median":-0.176975,"eighty":0.614746,"marketCap":150634710},{"date":"2021-02-05","current":-0.32078,"twenty":-2.66132,"median":-0.177345,"eighty":0.540199,"marketCap":168839379},{"date":"2021-02-12","current":-0.357402,"twenty":-2.66132,"median":-0.178762,"eighty":0.299811,"marketCap":188114910},{"date":"2021-02-19","current":-0.356046,"twenty":-2.66132,"median":-0.180096,"eighty":0.293846,"marketCap":187401002},{"date":"2021-02-26","current":-0.339769,"twenty":-2.66132,"median":-0.18127,"eighty":0.278675,"marketCap":178834099},{"date":"2021-03-05","current":-0.52729,"twenty":-3.043973,"median":-0.183041,"eighty":0.257822,"marketCap":146245483},{"date":"2021-03-12","current":-0.577941,"twenty":-3.043973,"median":-0.185822,"eighty":0.237224,"marketCap":160293694},{"date":"2021-03-19","current":-0.519498,"twenty":-3.043973,"median":-0.188879,"eighty":0.223871,"marketCap":144084220},{"date":"2021-03-26","current":-0.520796,"twenty":-2.66132,"median":-0.195316,"eighty":0.173892,"marketCap":144444430},{"date":"2021-04-01","current":-0.520796,"twenty":-2.66132,"median":-0.198029,"eighty":-0.002773,"marketCap":144444430},{"date":"2021-04-09","current":-0.483133,"twenty":-3.043973,"median":-0.202085,"eighty":-0.003094,"marketCap":133998324},{"date":"2021-04-16","current":-0.486815,"twenty":-3.043973,"median":-0.204788,"eighty":-0.003161,"marketCap":135019521},{"date":"2021-04-23","current":-0.515682,"twenty":-3.043973,"median":-0.207878,"eighty":-0.003276,"marketCap":143026069},{"date":"2021-04-30","current":-0.532741,"twenty":-3.043973,"median":-0.210329,"eighty":-0.004577,"marketCap":147757212},{"date":"2021-05-07","current":-0.590476,"twenty":-3.043973,"median":-0.21151,"eighty":-0.008134,"marketCap":163770309},{"date":"2021-05-14","current":-0.803793,"twenty":-3.043973,"median":-0.213835,"eighty":-0.009471,"marketCap":184583018},{"date":"2021-05-21","current":-0.814891,"twenty":-3.043973,"median":-0.214877,"eighty":-0.009471,"marketCap":187131501},{"date":"2021-05-28","current":-0.841842,"twenty":-3.043973,"median":-0.216246,"eighty":-0.009471,"marketCap":193320676},{"date":"2021-06-04","current":-1.008308,"twenty":-3.043973,"median":-0.21745,"eighty":-0.009471,"marketCap":231547928},{"date":"2021-06-11","current":-1.009894,"twenty":-3.043973,"median":-0.219342,"eighty":-0.009471,"marketCap":231911997},{"date":"2021-06-18","current":-0.959161,"twenty":-3.043973,"median":-0.219969,"eighty":-0.009471,"marketCap":220261787},{"date":"2021-06-25","current":-1.030504,"twenty":-3.043973,"median":-0.220653,"eighty":-0.009471,"marketCap":236644895},{"date":"2021-07-02","current":-0.992454,"twenty":-3.043973,"median":-0.221995,"eighty":-0.009471,"marketCap":227907237},{"date":"2021-07-09","current":-0.919526,"twenty":-3.043973,"median":-0.223126,"eighty":-0.009471,"marketCap":211160060},{"date":"2021-07-16","current":-0.806964,"twenty":-3.043973,"median":-0.224421,"eighty":-0.009471,"marketCap":185311156},{"date":"2021-07-23","current":-0.883062,"twenty":-3.043973,"median":-0.225106,"eighty":-0.009471,"marketCap":202786471},{"date":"2021-07-30","current":-0.948064,"twenty":-3.043973,"median":-0.226177,"eighty":-0.009582,"marketCap":217713303},{"date":"2021-08-06","current":-1.059041,"twenty":-3.043973,"median":-0.227027,"eighty":-0.010935,"marketCap":243198138},{"date":"2021-08-13","current":133.685349,"twenty":-3.043973,"median":-0.227203,"eighty":-0.011807,"marketCap":319641669},{"date":"2021-08-20","current":130.327954,"twenty":-3.043973,"median":-0.227203,"eighty":-0.011807,"marketCap":311614138},{"date":"2021-08-27","current":146.199274,"twenty":-3.043973,"median":-0.227203,"eighty":-0.011807,"marketCap":349562464},{"date":"2021-09-03","current":153.524499,"twenty":-3.043973,"median":-0.227203,"eighty":-0.004577,"marketCap":367077076},{"date":"2021-09-10","current":156.729284,"twenty":-3.043973,"median":-0.227203,"eighty":-0.003197,"marketCap":374739719},{"date":"2021-09-17","current":174.43191,"twenty":-3.043973,"median":-0.227203,"eighty":-0.002948,"marketCap":417066698},{"date":"2021-09-24","current":176.568434,"twenty":-3.043973,"median":-0.227203,"eighty":-0.002766,"marketCap":422175126},{"date":"2021-10-01","current":207.395421,"twenty":-3.043973,"median":-0.227203,"eighty":0.222451,"marketCap":495882452},{"date":"2021-10-08","current":208.311074,"twenty":-2.287415,"median":-0.227027,"eighty":0.23211,"marketCap":498071778},{"date":"2021-10-15","current":175.80539,"twenty":-2.287415,"median":-0.227027,"eighty":0.253958,"marketCap":420350688},{"date":"2021-10-22","current":182.062353,"twenty":-2.287415,"median":-0.226511,"eighty":0.276345,"marketCap":435311085},{"date":"2021-10-29","current":195.339322,"twenty":-1.909137,"median":-0.225208,"eighty":0.284016,"marketCap":467056320},{"date":"2021-11-05","current":199.917588,"twenty":-1.909137,"median":-0.224657,"eighty":0.299328,"marketCap":478002952},{"date":"2021-11-12","current":6.485694,"twenty":-1.909137,"median":-0.224541,"eighty":0.306317,"marketCap":517162779},{"date":"2021-11-19","current":5.375696,"twenty":-1.909137,"median":-0.224541,"eighty":3.265836,"marketCap":428652600},{"date":"2021-11-26","current":5.462844,"twenty":-1.909137,"median":-0.224541,"eighty":3.318245,"marketCap":435601747},{"date":"2021-12-03","current":4.495036,"twenty":-1.909137,"median":-0.224541,"eighty":3.372152,"marketCap":358429649},{"date":"2021-12-10","current":4.751895,"twenty":-1.909137,"median":-0.224541,"eighty":3.397608,"marketCap":378911343},{"date":"2021-12-17","current":4.605118,"twenty":-1.909137,"median":-0.224541,"eighty":3.417074,"marketCap":367207518},{"date":"2021-12-23","current":4.903258,"twenty":-1.909137,"median":-0.224541,"eighty":3.453011,"marketCap":390980913},{"date":"2021-12-31","current":4.797763,"twenty":-1.909137,"median":-0.224541,"eighty":3.509913,"marketCap":382568788},{"date":"2022-01-07","current":4.994994,"twenty":-1.530858,"median":-0.22451,"eighty":3.590772,"marketCap":398295804},{"date":"2022-01-14","current":5.251853,"twenty":-1.530858,"median":-0.22451,"eighty":3.662647,"marketCap":418777498},{"date":"2022-01-21","current":4.563837,"twenty":-1.530858,"median":-0.22451,"eighty":3.737517,"marketCap":363915817},{"date":"2022-01-28","current":5.132597,"twenty":-1.530858,"median":-0.22451,"eighty":3.821373,"marketCap":409268140},{"date":"2022-02-04","current":5.673836,"twenty":-1.530858,"median":-0.22451,"eighty":4.090905,"marketCap":452425995},{"date":"2022-02-11","current":5.614208,"twenty":-1.530858,"median":-0.22451,"eighty":4.263106,"marketCap":447671316},{"date":"2022-02-18","current":5.39863,"twenty":-1.530858,"median":-0.22451,"eighty":4.434756,"marketCap":430481323},{"date":"2022-02-25","current":5.98115,"twenty":-1.530858,"median":-0.22451,"eighty":4.513383,"marketCap":476930880},{"date":"2022-03-04","current":7.178297,"twenty":-1.530858,"median":-0.224421,"eighty":4.596862,"marketCap":572390205},{"date":"2022-03-11","current":5.06258,"twenty":-1.530858,"median":-0.224161,"eighty":4.650986,"marketCap":590995441},{"date":"2022-03-18","current":4.456828,"twenty":-1.530858,"median":-0.224161,"eighty":4.691727,"marketCap":520281169},{"date":"2022-03-25","current":5.395273,"twenty":-1.530858,"median":-0.224161,"eighty":4.743638,"marketCap":629833331},{"date":"2022-04-01","current":5.263451,"twenty":-1.530858,"median":-0.223126,"eighty":4.790424,"marketCap":614444733},{"date":"2022-04-08","current":5.464322,"twenty":-1.530858,"median":-0.220953,"eighty":4.875738,"marketCap":637894025},{"date":"2022-04-14","current":5.903728,"twenty":-1.530858,"median":-0.219822,"eighty":4.907845,"marketCap":689189352},{"date":"2022-04-22","current":5.583589,"twenty":-1.530858,"median":-0.216912,"eighty":4.999086,"marketCap":651817043},{"date":"2022-04-29","current":5.833099,"twenty":-1.530858,"median":-0.214099,"eighty":5.057558,"marketCap":680944369},{"date":"2022-05-06","current":6.2554,"twenty":-1.530858,"median":-0.21142,"eighty":5.136266,"marketCap":728247452},{"date":"2022-05-13","current":5.776639,"twenty":-1.530858,"median":-0.20888,"eighty":5.227332,"marketCap":672510487},{"date":"2022-05-20","current":6.274299,"twenty":-1.530858,"median":-0.204788,"eighty":5.268229,"marketCap":730447595},{"date":"2022-05-27","current":7.776729,"twenty":-1.530858,"median":-0.202085,"eighty":5.326158,"marketCap":905358992},{"date":"2022-06-03","current":8.466524,"twenty":-1.530858,"median":-0.199194,"eighty":5.38328,"marketCap":985664225},{"date":"2022-06-10","current":8.463374,"twenty":-1.530858,"median":-0.195316,"eighty":5.455506,"marketCap":985297534},{"date":"2022-06-17","current":6.044367,"twenty":-1.530858,"median":-0.187522,"eighty":5.488941,"marketCap":703679184},{"date":"2022-06-24","current":5.033298,"twenty":-1.909137,"median":-0.186462,"eighty":5.50596,"marketCap":585971514},{"date":"2022-07-01","current":5.014399,"twenty":-1.909137,"median":-0.183109,"eighty":5.50596,"marketCap":583771371},{"date":"2022-07-08","current":5.080544,"twenty":-1.909137,"median":-0.181075,"eighty":5.50596,"marketCap":591471873},{"date":"2022-07-15","current":5.017549,"twenty":-1.909137,"median":-0.170852,"eighty":5.50596,"marketCap":584138062},{"date":"2022-07-22","current":5.341973,"twenty":-1.909137,"median":-0.166897,"eighty":5.512382,"marketCap":621907189},{"date":"2022-07-29","current":5.899479,"twenty":-1.909137,"median":-0.162764,"eighty":5.577514,"marketCap":686811418},{"date":"2022-08-05","current":4.367858,"twenty":-1.909137,"median":-0.155064,"eighty":5.579944,"marketCap":649321384},{"date":"2022-08-12","current":4.750354,"twenty":-1.909137,"median":-0.143096,"eighty":5.579944,"marketCap":706182862},{"date":"2022-08-19","current":5.061286,"twenty":-1.909137,"median":-0.132121,"eighty":5.579944,"marketCap":752405740},{"date":"2022-08-26","current":5.39196,"twenty":-1.909137,"median":-0.126091,"eighty":5.579944,"marketCap":801563404},{"date":"2022-09-02","current":4.972448,"twenty":-1.909137,"median":-0.122977,"eighty":5.579944,"marketCap":739199203},{"date":"2022-09-09","current":4.762692,"twenty":-1.909137,"median":-0.122199,"eighty":5.579944,"marketCap":708017103},{"date":"2022-09-16","current":4.382664,"twenty":-1.909137,"median":-0.118307,"eighty":5.579944,"marketCap":651522474},{"date":"2022-09-23","current":3.741058,"twenty":-1.909137,"median":-0.116298,"eighty":5.579944,"marketCap":556141931},{"date":"2022-09-30","current":4.024845,"twenty":-1.909137,"median":-0.107956,"eighty":5.579944,"marketCap":598329479},{"date":"2022-10-07","current":4.663984,"twenty":-1.909137,"median":-0.105075,"eighty":5.579944,"marketCap":693343173},{"date":"2022-10-14","current":4.395003,"twenty":-1.909137,"median":-0.103638,"eighty":5.579944,"marketCap":653356715},{"date":"2022-10-21","current":4.481373,"twenty":-1.909137,"median":-0.102558,"eighty":5.579944,"marketCap":666196403},{"date":"2022-10-28","current":4.508518,"twenty":-1.909137,"median":-0.101479,"eighty":5.579944,"marketCap":670231734},{"date":"2022-11-04","current":4.403711,"twenty":-1.909137,"median":-0.100939,"eighty":5.579944,"marketCap":765298881},{"date":"2022-11-11","current":4.325338,"twenty":-1.909137,"median":-0.100399,"eighty":5.579944,"marketCap":751678843},{"date":"2022-11-18","current":4.149528,"twenty":-1.909137,"median":-0.09807,"eighty":5.579944,"marketCap":721125785},{"date":"2022-11-25","current":4.289329,"twenty":-1.909137,"median":-0.0977,"eighty":5.579944,"marketCap":745420988},{"date":"2022-12-02","current":4.289329,"twenty":-1.909137,"median":-0.096514,"eighty":5.579944,"marketCap":745420988},{"date":"2022-12-09","current":3.672936,"twenty":-1.909137,"median":-0.095001,"eighty":5.579944,"marketCap":638301231},{"date":"2022-12-16","current":3.651754,"twenty":-1.909137,"median":-0.094461,"eighty":5.579944,"marketCap":634620140},{"date":"2022-12-23","current":3.679291,"twenty":-1.909137,"median":-0.092842,"eighty":5.579944,"marketCap":639405558},{"date":"2022-12-30","current":3.607272,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":626889848},{"date":"2023-01-06","current":3.497127,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":607748173},{"date":"2023-01-13","current":3.651754,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":634620140},{"date":"2023-01-20","current":3.677173,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":639037449},{"date":"2023-01-27","current":3.458999,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":601122209},{"date":"2023-02-03","current":3.232353,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":561734532},{"date":"2023-02-10","current":3.374272,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":586397844},{"date":"2023-02-17","current":3.094671,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":537807438},{"date":"2023-02-24","current":3.069253,"twenty":-1.909137,"median":-0.092302,"eighty":5.552745,"marketCap":533390129},{"date":"2023-03-03","current":3.300135,"twenty":-1.909137,"median":-0.092302,"eighty":5.50596,"marketCap":573514024},{"date":"2023-03-10","current":2.923098,"twenty":-1.909137,"median":-0.092302,"eighty":5.476483,"marketCap":507990599},{"date":"2023-03-17","current":2.108279,"twenty":-1.909137,"median":-0.092302,"eighty":5.463435,"marketCap":510557771},{"date":"2023-03-24","current":2.123501,"twenty":-1.909137,"median":-0.092302,"eighty":5.422256,"marketCap":514244109},{"date":"2023-03-31","current":2.193524,"twenty":-1.530858,"median":-0.092032,"eighty":5.382618,"marketCap":531201262},{"date":"2023-04-06","current":2.330524,"twenty":-1.530858,"median":-0.092032,"eighty":5.343213,"marketCap":564378301},{"date":"2023-04-14","current":2.350313,"twenty":-1.909137,"median":-0.092302,"eighty":5.280538,"marketCap":569170540},{"date":"2023-04-21","current":2.223968,"twenty":-1.909137,"median":-0.092302,"eighty":5.260602,"marketCap":538573937},{"date":"2023-04-28","current":2.115524,"twenty":-1.909137,"median":-0.092302,"eighty":5.201307,"marketCap":512312287},{"date":"2023-05-05","current":1.996726,"twenty":-1.909137,"median":-0.092302,"eighty":5.168743,"marketCap":483543130},{"date":"2023-05-12","current":2.281272,"twenty":-1.036156,"median":-0.091762,"eighty":5.168743,"marketCap":527434536},{"date":"2023-05-19","current":2.75986,"twenty":-1.024459,"median":-0.090143,"eighty":5.168743,"marketCap":638085138},{"date":"2023-05-26","current":2.321154,"twenty":-1.01264,"median":-0.089603,"eighty":5.168743,"marketCap":536655419},{"date":"2023-06-02","current":2.211079,"twenty":-1.007179,"median":-0.089381,"eighty":5.168743,"marketCap":511205781},{"date":"2023-06-08","current":2.412086,"twenty":-1.002776,"median":-0.088524,"eighty":5.168743,"marketCap":557679034},{"date":"2023-06-16","current":2.281272,"twenty":-0.996257,"median":-0.087444,"eighty":5.170762,"marketCap":527434536},{"date":"2023-06-23","current":2.212674,"twenty":-0.992137,"median":-0.086365,"eighty":5.172782,"marketCap":511574616},{"date":"2023-06-30","current":2.432825,"twenty":-0.971844,"median":-0.085356,"eighty":5.174801,"marketCap":562473893},{"date":"2023-07-07","current":2.404109,"twenty":-0.965101,"median":-0.083844,"eighty":5.175295,"marketCap":555834857},{"date":"2023-07-14","current":2.552472,"twenty":-0.948698,"median":-0.071339,"eighty":5.175295,"marketCap":590136544},{"date":"2023-07-21","current":2.534923,"twenty":-0.932417,"median":-0.066142,"eighty":5.175295,"marketCap":586079355},{"date":"2023-07-28","current":2.616283,"twenty":-0.919526,"median":-0.064441,"eighty":5.175295,"marketCap":604889957},{"date":"2023-08-04","current":3.054488,"twenty":-0.910289,"median":1.988024,"eighty":5.175295,"marketCap":608903040},{"date":"2023-08-11","current":3.08041,"twenty":-0.902047,"median":2.083924,"eighty":5.175295,"marketCap":614070574},{"date":"2023-08-18","current":2.965497,"twenty":-0.888634,"median":2.123501,"eighty":5.175295,"marketCap":591163008},{"date":"2023-08-25","current":2.859852,"twenty":-0.875322,"median":2.155243,"eighty":5.175295,"marketCap":570102825},{"date":"2023-09-01","current":2.963644,"twenty":-0.843527,"median":2.163079,"eighty":5.175295,"marketCap":590793531},{"date":"2023-09-08","current":3.008126,"twenty":-0.838989,"median":2.183959,"eighty":5.175295,"marketCap":599660976},{"date":"2023-09-15","current":3.00998,"twenty":-0.830972,"median":2.209483,"eighty":5.175295,"marketCap":600030453},{"date":"2023-09-22","current":2.824636,"twenty":-0.82472,"median":2.223968,"eighty":5.175295,"marketCap":563082765},{"date":"2023-09-29","current":2.930282,"twenty":-0.808354,"median":2.258979,"eighty":5.175295,"marketCap":584142947},{"date":"2023-10-06","current":2.720844,"twenty":-0.779061,"median":2.281272,"eighty":5.175295,"marketCap":542392059},{"date":"2023-10-13","current":2.909894,"twenty":-0.709616,"median":2.322913,"eighty":5.175295,"marketCap":580078701},{"date":"2023-10-20","current":3.047049,"twenty":-0.674037,"median":2.333568,"eighty":5.175295,"marketCap":607419990},{"date":"2023-10-27","current":2.94511,"twenty":-0.64577,"median":2.353357,"eighty":5.177269,"marketCap":587098762},{"date":"2023-11-03","current":2.967351,"twenty":-0.611654,"median":2.403591,"eighty":5.177269,"marketCap":591532484},{"date":"2023-11-10","current":3.21558,"twenty":-0.589722,"median":2.432825,"eighty":5.177269,"marketCap":528294083},{"date":"2023-11-17","current":3.238146,"twenty":-0.574045,"median":2.474302,"eighty":5.177269,"marketCap":532001410},{"date":"2023-11-24","current":3.271994,"twenty":-0.567551,"median":2.534923,"eighty":5.177269,"marketCap":537562400},{"date":"2023-12-01","current":3.116292,"twenty":-0.552423,"median":2.603521,"eighty":5.177269,"marketCap":511981844},{"date":"2023-12-08","current":3.039569,"twenty":-0.540018,"median":2.650582,"eighty":5.176775,"marketCap":499376933},{"date":"2023-12-15","current":3.134344,"twenty":-0.525991,"median":2.722803,"eighty":5.176775,"marketCap":514947706},{"date":"2023-12-22","current":3.174962,"twenty":-0.514043,"median":2.780154,"eighty":5.176775,"marketCap":521620894},{"date":"2023-12-29","current":3.132088,"twenty":-0.509108,"median":2.824636,"eighty":5.177269,"marketCap":514576973},{"date":"2024-01-05","current":3.09147,"twenty":-0.506571,"median":2.854539,"eighty":5.177452,"marketCap":507903785},{"date":"2024-01-12","current":3.030543,"twenty":-0.492979,"median":2.875606,"eighty":5.177452,"marketCap":497894002},{"date":"2024-01-19","current":3.152397,"twenty":-0.485385,"median":2.902481,"eighty":5.177636,"marketCap":517913567},{"date":"2024-01-26","current":3.271994,"twenty":-0.475072,"median":2.921015,"eighty":5.177452,"marketCap":537562400},{"date":"2024-02-02","current":3.278763,"twenty":-0.367032,"median":2.930282,"eighty":5.177452,"marketCap":538674598},{"date":"2024-02-09","current":2.798119,"twenty":-0.357402,"median":2.930282,"eighty":5.177452,"marketCap":459708535},{"date":"2024-02-16","current":2.922229,"twenty":-0.347636,"median":2.930282,"eighty":5.177452,"marketCap":480098833},{"date":"2024-02-23","current":2.928999,"twenty":-0.340583,"median":2.931209,"eighty":5.177452,"marketCap":481211031},{"date":"2024-03-01","current":2.942538,"twenty":-0.324849,"median":2.933989,"eighty":5.177269,"marketCap":483435427},{"date":"2024-03-08","current":3.077931,"twenty":-0.308573,"median":2.937696,"eighty":5.177269,"marketCap":505679389},{"date":"2024-03-15","current":8.394693,"twenty":-0.286193,"median":2.947051,"eighty":5.233506,"marketCap":510875813},{"date":"2024-03-22","current":8.692981,"twenty":-0.254318,"median":2.965497,"eighty":5.26659,"marketCap":529028760},{"date":"2024-03-28","current":8.832994,"twenty":-0.233295,"median":2.969204,"eighty":5.282283,"marketCap":537549532},{"date":"2024-04-05","current":9.131283,"twenty":-0.21512,"median":3.005346,"eighty":5.343213,"marketCap":555702480},{"date":"2024-04-12","current":9.173895,"twenty":-0.210372,"median":3.015541,"eighty":5.392623,"marketCap":558295758},{"date":"2024-04-19","current":8.717331,"twenty":-0.203047,"median":3.02876,"eighty":5.44914,"marketCap":530510634},{"date":"2024-04-26","current":8.905871,"twenty":-0.195316,"median":3.047049,"eighty":5.464813,"marketCap":541984599},{"date":"2024-05-03","current":8.284531,"twenty":-0.185822,"median":3.054488,"eighty":5.477412,"marketCap":504171720},{"date":"2024-05-10","current":10.439414,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":503430291},{"date":"2024-05-17","current":10.316416,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":497498859},{"date":"2024-05-24","current":10.36254,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":499723146},{"date":"2024-05-31","current":10.477851,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":505283863},{"date":"2024-06-07","current":10.031985,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":483782422},{"date":"2024-06-14","current":9.993548,"twenty":-0.185267,"median":3.057622,"eighty":5.500456,"marketCap":481928850},{"date":"2024-06-21","current":10.039672,"twenty":-0.185406,"median":3.057622,"eighty":5.491591,"marketCap":484153137},{"date":"2024-06-28","current":9.924362,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":478592419},{"date":"2024-07-05","current":10.055047,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":484894566},{"date":"2024-07-12","current":10.024297,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":483411708},{"date":"2024-07-15","current":10.108858,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":487489567},{"date":"2024-08-02","current":10.01661,"twenty":-0.186229,"median":3.041488,"eighty":5.43,"marketCap":483040993},{"date":"2024-08-09","current":11.621635,"twenty":-0.186229,"median":3.041488,"eighty":5.450163,"marketCap":469293243},{"date":"2024-08-16","current":12.062963,"twenty":-0.186229,"median":3.041488,"eighty":5.466384,"marketCap":487114505},{"date":"2024-08-23","current":12.127323,"twenty":-0.186229,"median":3.041488,"eighty":5.48274,"marketCap":489713439},{"date":"2024-08-30","current":12.347987,"twenty":-0.186229,"median":3.041488,"eighty":5.514296,"marketCap":498624070},{"date":"2024-09-06","current":11.391777,"twenty":-0.186229,"median":3.041488,"eighty":5.57201,"marketCap":460011335},{"date":"2024-09-13","current":10.830922,"twenty":-0.186229,"median":3.041488,"eighty":5.599109,"marketCap":437363481},{"date":"2024-09-20","current":11.253862,"twenty":-0.186229,"median":3.041488,"eighty":5.638997,"marketCap":454442191},{"date":"2024-09-27","current":10.683813,"twenty":-0.186229,"median":3.041488,"eighty":5.705563,"marketCap":431423060},{"date":"2024-10-04","current":11.796327,"twenty":-0.186229,"median":3.041488,"eighty":5.810515,"marketCap":476347492},{"date":"2024-10-11","current":11.373388,"twenty":-0.186229,"median":3.041488,"eighty":5.902028,"marketCap":459268783},{"date":"2024-10-18","current":10.849311,"twenty":-0.186229,"median":3.041488,"eighty":5.986654,"marketCap":438106034},{"date":"2024-10-25","current":10.371206,"twenty":-0.186229,"median":3.041488,"eighty":6.158999,"marketCap":418799666},{"date":"2024-10-31","current":10.279263,"twenty":-0.186229,"median":3.041488,"eighty":6.2554,"marketCap":415086903},{"date":"2024-11-08","current":9.658709,"twenty":-0.186364,"median":3.040529,"eighty":6.338506,"marketCap":455842770},{"date":"2024-11-15","current":9.251565,"twenty":-0.185683,"median":3.047049,"eighty":6.476802,"marketCap":436627626},{"date":"2024-11-22","current":9.251565,"twenty":-0.181075,"median":3.056969,"eighty":6.574785,"marketCap":436627626},{"date":"2024-11-29","current":9.235818,"twenty":-0.177176,"median":3.070198,"eighty":6.933226,"marketCap":435884430},{"date":"2024-12-06","current":8.802766,"twenty":-0.167619,"median":3.080127,"eighty":7.38553,"marketCap":415446541},{"date":"2024-12-13","current":8.912997,"twenty":-0.164235,"median":3.088696,"eighty":7.999101,"marketCap":420648913},{"date":"2024-12-20","current":8.267356,"twenty":-0.15664,"median":3.111918,"eighty":8.279954,"marketCap":390177879},{"date":"2024-12-27","current":8.582303,"twenty":-0.148102,"median":3.125881,"eighty":8.3357,"marketCap":405041798},{"date":"2025-01-03","current":9.456281,"twenty":-0.139634,"median":3.133216,"eighty":8.412503,"marketCap":446289173},{"date":"2025-01-10","current":9.621628,"twenty":-0.131539,"median":3.139153,"eighty":8.463374,"marketCap":454092731},{"date":"2025-01-17","current":9.928701,"twenty":-0.126091,"median":3.15691,"eighty":8.522531,"marketCap":468585052},{"date":"2025-01-24","current":9.700365,"twenty":-0.122977,"median":3.16669,"eighty":8.626019,"marketCap":457808711},{"date":"2025-01-31","current":9.566512,"twenty":-0.121996,"median":3.190758,"eighty":8.686894,"marketCap":451491545},{"date":"2025-02-07","current":9.330302,"twenty":-0.11788,"median":3.219644,"eighty":8.802766,"marketCap":440343606},{"date":"2025-02-14","current":9.527144,"twenty":-0.115194,"median":3.232353,"eighty":8.857882,"marketCap":449633555},{"date":"2025-02-21","current":9.842091,"twenty":-0.107956,"median":3.265224,"eighty":8.881503,"marketCap":464497475},{"date":"2025-02-28","current":9.220071,"twenty":-0.105075,"median":3.278763,"eighty":8.930237,"marketCap":435141234},{"date":"2025-03-07","current":8.621672,"twenty":-0.103543,"median":3.290923,"eighty":8.933445,"marketCap":406899788},{"date":"2025-03-14","current":6.607418,"twenty":-0.103543,"median":3.309215,"eighty":8.933445,"marketCap":416174831},{"date":"2025-03-21","current":6.87831,"twenty":-0.103543,"median":3.353299,"eighty":8.933445,"marketCap":433237258},{"date":"2025-03-28","current":6.801754,"twenty":-0.103543,"median":3.420872,"eighty":8.933445,"marketCap":428415268},{"date":"2025-04-04","current":6.224635,"twenty":-0.103543,"median":3.504541,"eighty":8.933445,"marketCap":392064881},{"date":"2025-04-11","current":5.417847,"twenty":-0.103519,"median":3.550081,"eighty":8.932686,"marketCap":341248525},{"date":"2025-04-17","current":5.529738,"twenty":-0.103519,"median":3.578189,"eighty":8.932686,"marketCap":348296049},{"date":"2025-04-25","current":5.512071,"twenty":-0.102594,"median":3.627395,"eighty":8.933445,"marketCap":347183282},{"date":"2025-04-30","current":5.435514,"twenty":-0.101576,"median":3.654931,"eighty":8.933445,"marketCap":342361292}],"updateTime":1746111083276}}}